期刊文献+

胆囊癌p53、p73和p21^(WAF1)蛋白的表达 被引量:1

Expression of p53,p73 and p21^(WAF1) proteins in carcinoma of the gallbladder
下载PDF
导出
摘要 目的探讨p53、p73和p21WAF1基因在胆囊癌中的表达。方法应用免疫组化SP法检测48例胆囊癌、32例癌旁组织、20例正常胆囊组织p53、p73和p21WAF1蛋白的表达,分析p73和p21WAF1相互关系。结果48例胆囊癌中,p53、p73和p21WAF1蛋白阳性表达率分别为56.2%、52.1%和43.8%,均高于癌旁组织和正常组织(P<0.01)。胆囊癌中p73蛋白的表达与Nevin分期有关(P<0.05),p21WAF1蛋白的表达与淋巴结转移、Nevin分期有关(P<0.05)。结论p53、p73和p21WAF1基因在胆囊癌高表达,提示三者在胆囊癌发生发展中起重要作用。胆囊癌中p73与p21WAF1表达无相关性。 Objective To study the expression of p53,p73 and p21^WAF1 proteins in carcinoma of the gallbladder. Methods Immunohistochemical method was used to detect the proteins of p53, p73 and p21^WAF1 in 48 patients with carcinoma of the gallbladder, 32 cases with paratumor tissue and 20 normal gall bladde tissues. The relationship of p73 and p21^WAF1 expression was analyzed. Results The positive expression rates of p53, p73 and p21^WAF1 in 48 patients with carcinoma of the gallbladder were 56.2%,52. 1% and 43. 8%, respectively, which were .significantly higher than those in the tumoradjacent tissues and normal gallbladder tissues (P〈0.01). The p73 protein was markedlly correlated to Nevin staging of the tumor (P〈0. 05). Meanwhile, p21^WAF1 was correlated to tumor lymph node metastasis and Nevin staging (P〈0. 05). No significant association was found between the expression of p73 and that of p21^WAF1. Conclusion p53, p73 and p21^WAF1 proteins are upregulated indicating that they may play an important role in carcinogensis of gallbladder carcinoma. There is no correlation in the expression of p73 and p21^WAF1 proteins in carcinoma of the gallbladder.
出处 《江苏医药》 CAS CSCD 北大核心 2008年第6期552-554,共3页 Jiangsu Medical Journal
基金 桂林市科学研究与技术开发计划项目(20063009)
关键词 胆囊肿瘤 p53蛋白 P73蛋白 P21^WAF1蛋白 Gallbladder neoplasms p53 Protein p73 Proteins p21^WAF1 Protein
  • 相关文献

参考文献6

二级参考文献24

  • 1Rau B,Sturm I,Lage H,et al.Dynamic expression profile of p21WAF1/CIP1 and Ki-56 predicts survival in rectal carcinoma treated with reoperative radiochemotherapy.J Clin Oncol,2003,21:3391-3401.
  • 2Elkablawy MA,Maxwell P,Williamson K,et al.Apoptosis and cellcycle regulatory proteins in colorectal carcinoma:relationship to tumor stage and patient survival.J Pathol,2001,194:436-443.
  • 3Stewart MC,Kadlcek RM,Robbins PD,et al.Expression and activity of the CDK inhibitor p57 kip2 in chondrocytes undergoing hypertrophic differentiation.J Bone Miner Res,2004,19:123-132.
  • 4Gong J,Ammanamanchi S,Ko TC,et al.Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.Cancer Res,2003,63:3340-3346.
  • 5Yan Z,Deng X,Friedman E.Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factorbeta receptor Ⅲ.J Biol Chem,2001,276:1555-1563.
  • 6Hatib ZA,Matsushine H,Valentine M,et al.Co-amplification of the CDK4 gene with MDM2 and GLI in human sarcomas.Cancer Res,1993,53:5535-5541.
  • 7Huang ZY,Wu Y,Hedrick N,et al.T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21 (CIP1/WAF1) expression[J].Mol Cell Biol,2003,23(2):566-578.
  • 8Strakova N,Ehrmann J,Dzubak P,et al.The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines[J].J Pharmacol Exp Ther,2004,309(3):1239-1247.
  • 9Weng MS,Ho YS,Lin JK.Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1expression:involvement of p38 mitogen-activated protein kinase[J].Biochem Pharmacol,2005,69(12):1815-1827.
  • 10Chen J,Willingham T,Shuford M,et al.Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells[J].Oncogene,1996,13(7):1395-1403.

共引文献9

同被引文献8

  • 1Hardcastle A, Boxall K, Richards J, et al. Solid-phase immunoassays in mechanism based drug discovery: their application in the development of inhlhitors of the molecular chaperone heatshock protein 90 [J]. Assay Drug Dev Technol, 2005,3 (3): 273-285.
  • 2Joanna LH, Swee YS, Steve H, et al. Silencing of HSP90 coehaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 Inhibitor 17-allylamino- 17-demethoxygeldanamy-cin [J]. Cancer Res, 2008,68(4) :1187-1197.
  • 3Samakovli D, Thanou A, Valmas C, et al. Hsp90 canalizes developmental perturbation[J]. J Exp Bot, 2007,58 (13) :3513- 3524.
  • 4Zhao R, Kakihara Y, Gribun A, et al. Molecular chaperone HSP90 stabilizes Pih1/Nop17 to maintain R2TP complex activity that regulates snoRNA accumulation[J]. J Cell Biol, 2008,180(3) :563-578.
  • 5Xiao L, Rasouli P, Ruden DM. Possible effects of early treatments of HsP90 inhibitors on preventing the evolution of drug resistance to other anti-cancer drugs[J]. Curr Med Chem, 2007,14(2) ; 223- 232.
  • 6Barker CR, Hamlett J, Pennington SR, et al. The topoisomerase II-HSP90 complex: a new chemotherapeutic target[J]? Int J Cancer, 2006,118 (11) : 2685-2693.
  • 7Sebastian KW, Klaus R, Johannes B. The HSP90 chaperone machinery[J]. J Biol Chem,2008,283(27):18473-18477.
  • 8McCarthy MM,Pick E,Kluger Y,et al. HSP90 as a marker of progression in melanoma [J]. Annals of Oncology, 2008, 19 (3) :590-594.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部